{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T15:34:00Z","timestamp":1782315240658,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007077","name":"National Institute of Biomedical Innovation","doi-asserted-by":"publisher","award":["24790154"],"award-info":[{"award-number":["24790154"]}],"id":[{"id":"10.13039\/501100007077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.jneuroim.2013.11.002","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T12:15:29Z","timestamp":1384172129000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Vaccine efficacy of transcutaneous immunization with amyloid \u03b2 using a dissolving microneedle array in a mouse model of Alzheimer's disease"],"prefix":"10.1016","volume":"266","author":[{"given":"Kazuhiko","family":"Matsuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Shu","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Kamiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Hirobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsaku","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.11.002_bb0005","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease","volume":"6","author":"Bard","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.WNL.0000148604.77591.67","article-title":"Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD","volume":"64","author":"Bayer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0015","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/eji.1830180716","article-title":"Interleukin 4 instructs uncommitted B lymphocytes to switch to IgG1 and IgE","volume":"18","author":"Bergstedt-Lindqvist","year":"1988","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0020","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1001\/archneurol.2012.90","article-title":"Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease","volume":"69","author":"Blennow","year":"2012","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0025","doi-asserted-by":"crossref","first-page":"e25542","DOI":"10.1371\/journal.pone.0025542","article-title":"Toll-like receptor agonists synergize with CD40L to induce either proliferation or plasma cell differentiation of mouse B cells","volume":"6","author":"Boeglin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0030","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jalz.2011.09.224","article-title":"Safety and biomarker effects of solanezumab in patients with Alzheimer's disease","volume":"8","author":"Farlow","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","article-title":"Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease","volume":"14","author":"Ferrer","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0045","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.140.4.1022","article-title":"IFN-\u03b3 regulates the isotypes of Ig secreted during in vivo humoral immune responses","volume":"140","author":"Finkelman","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0050","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.0022-202X.2004.23607.x","article-title":"Differential production of Th1- and Th2-type chemokines by mouse Langerhans cells and splenic dendritic cells","volume":"124","author":"Fujita","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0055","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3233\/JAD-2004-6504","article-title":"Development of a safe oral Abeta vaccine using recombinant adeno-associated virus vector for Alzheimer's disease","volume":"6","author":"Hara","year":"2004","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0065","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1007\/s11095-013-1092-6","article-title":"Development and Clinical study of a self-dissolving microneedle patch for transcutaneous immunization device","volume":"30","author":"Hirobe","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0070","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1038\/nm783","article-title":"Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease","volume":"8","author":"Hock","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0075","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","article-title":"Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease","volume":"38","author":"Hock","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10875-007-9087-x","article-title":"Toll or toll-free adjuvant path toward the optimal vaccine development","volume":"27","author":"Ishii","year":"2007","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2008.07.025","article-title":"A transcutaneous vaccination system using a hydrogel patch for viral and bacterial infection","volume":"131","author":"Ishii","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0080","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.bbrc.2010.07.120","article-title":"Reduction of amyloid beta-peptide accumulation in Tg2576 transgenic mice by oral vaccination","volume":"399","author":"Ishii-Katsuno","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0095","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/jama.2009.1547","article-title":"DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model","volume":"302","author":"Lambracht-Washington","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0100","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/ni731","article-title":"Dermal-resident CD14+ cells differentiate into Langerhans cells","volume":"2","author":"Larregina","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.neulet.2011.10.005","article-title":"Intranasal inoculation with an adenovirus vaccine encoding ten repeats of A\u03b23-10 induces Th2 immune response against amyloid-\u03b2 in wild-type mouse","volume":"505","author":"Li","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0110","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2009.02.153","article-title":"Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model","volume":"382","author":"Matsuda","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jconrel.2010.05.012","article-title":"Transcutaneous vaccination using a hydrogel patch induces effective immune responses to tetanus and diphtheria toxoid in hairless rat","volume":"149","author":"Matsuo","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0115","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jconrel.2012.04.001","article-title":"Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza","volume":"160","author":"Matsuo","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jconrel.2012.01.033","article-title":"A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens","volume":"161","author":"Matsuo","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0130","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/nm790","article-title":"Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis","volume":"8","author":"McLaurin","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0140","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1096\/fj.06-7685com","article-title":"Oral vaccination with a viral vector containing Abeta cDNA attenuates age-related Abeta accumulation and memory deficits without causing inflammation in a mouse Alzheimer model","volume":"21","author":"Mouri","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0135","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1089\/hum.2009.219","article-title":"Low concentrations of anti-A\u03b2 antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology","volume":"21","author":"Movsesyan","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0145","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report","volume":"9","author":"Nicoll","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/1523-1747.ep12276415","article-title":"Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin is mediated via interleukin-10","volume":"109","author":"Niizeki","year":"1997","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0155","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1073\/pnas.0609377104","article-title":"Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage","volume":"104","author":"Nikolic","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0160","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1016\/j.vaccine.2011.06.073","article-title":"Effect of rice-expressed amyloid \u03b2 in the Tg2576 Alzheimer's disease transgenic mouse model","volume":"29","author":"Nojima","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0165","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization","volume":"61","author":"Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0170","doi-asserted-by":"crossref","first-page":"e19323","DOI":"10.1371\/journal.pone.0019323","article-title":"Decreased dengue replication and an increased anti-viral humoral response with the use of combined Toll-like receptor 3 and 7\/8 agonists in macaques","volume":"6","author":"Sariol","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0175","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0180","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer's disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0185","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1523-1747.2003.12121.x","article-title":"Langerhans cells do not produce interferon-\u03b3","volume":"120","author":"Tada","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jneuroim.2013.11.002_bb0190","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active A\u03b2 immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"Lancet Neurol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813003111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813003111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:21:04Z","timestamp":1759047664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813003111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0165572813003111"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.11.002","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine efficacy of transcutaneous immunization with amyloid \u03b2 using a dissolving microneedle array in a mouse model of Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}